|
1 Munn DH, Sharma MD, Baban B, et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase [J]. Immunity, 2005, 22(5): 633-642.
|
|
2 Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by tryptophan catabolism [J]. Cell Death Differ, 2002, 9(10): 1069-1077.
|
|
3 Mellor AL, Munn DH. IDO expression by dendritic cells: Tolerance and tryptophan catabolism [J]. NatRev Immunol, 2004, 4: 762-774.
|
|
4 Uyttenhove C, Pilotte L, The'ate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine2，3-dioxygenase [J]. Nat Med, 2003, 9: 1269-1274.
|
|
5 Curti A, Aluigi M, Pandolfi S, et al. Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2，3-dioxygenase[J]. Leukemia. 2007, 21: 353-355.
|
|
6 Munn DH. Indoleamine 2, 3-dioxygenase, tumor-induced tolerance and counter-regulation [J]. Curr Opin Immunol, 2006, 18(2): 220-225.
|
|
7 Wood KJ, Sawitzki B. Interferon gamma: A crucial role in the function of induced regulatory T cells in vivo [J]. Trends Immunol, 2006, 27(4): 183-187.
|
|
8 King NJC, Thomas SR. Molecules in focus: Indoleamine 2, 3-dioxygenase [J]. Int J Biochem Cell Biol, 2007, 39(12): 2167-2172.
|
|
9 Bodaghi B, Goureau O, Zipeto D, et al. Role of IFN-gamma-induced indoleamine 2，3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells [J]. J Immunol, 1999, 162(2): 957-964.
|
|
10 MacKenzie CR, Hadding U, Daubener W. Interferon-gamma-induced activation of indoleamine 2，3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci [J]. J Infect Dis, 1998, 178(3): 875-878.
|
|
11 MacKenzie CR, Hucke C, Muller D，et al. Growth inhibition of multiresistant enterococci by interferon-gamma-activated human uro-epithelial cells [J]. J Med Microbiol, 1999, 48(10): 935-941.
|
|
12 Bozza S, Fallarino F, Pitzurra L, et al. A crucial role for tryptophan catabolism at the host/Candida albicans interface[J]. J Immunol, 2005, 174(5): 2910-2918.
|
|
13 Adams O, Besken K, Oberdorfer C, et al. Role of indoleamine-2，3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections [J]. J Virol, 2004, 78(5): 2632-2636.
|
|
14 Byrne GI, Lehmann LK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells [J]. Infect Immunol, 1986, 53(2): 347-351.
|
|
15 MacKenzie CR, Worku D, Daubener W. Regulation of IDO-mediated bacteriostasis in macrophages：Role of antibiotics and anti-inflammatory agents [J]. Adv Exp Med Biol, 2003, 527: 67-76.
|
|
16 Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation[J]? Immunol Today, 1999, 20(10): 469-473.
|
|
17 Potula R, Poluektova L, Knipe B, et al. Macrophages in an animal model of HIV-1 encephalitis[J]. Blood, 2005, 106(7): 2382-2390.
|
|
18 Hainz UB, Wekerle JT. Indoleamine 2, 3-dioxygenase in hematopoietic stem cell transplantation[J]. Curr Drug Metab, 2007, 8(3): 267-272.
|
|
19 Laurence JM, Wang C, Park ET, et al. Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection [J]. Transplantation, 2008, 85: 1357-1361.
|
|
20 Guillonneau C, Hill M, Hubert FX, et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RCT cells, IFN-gamma, and indoleamine 2，3-dioxygenase[J]. J Clin Invest, 2007, 117: 1096-1106.
|
|
21 Cook CH, Bickerstaff AA, Wang JJ, et al. Spontaneous renal allograft acceptance associated with " regulatory" dendritic cells and IDO [J]. J Immunol, 2008, 180: 3103-3112.
|
|
22 Jasperson LK, Bucher C, Panoskaltsis-Mortari A, et al. Indoleamine 2, 3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality [J]. Blood, 2008, 111: 3257-3265.
|
|
23 Hainz U, Obexer P, Winkler C. et al. Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation [J]. Blood, 2005, 105(10): 4127-4134.
|
|
24 Steckel NK, Kuhn U, Beelen DW, et al. Indoleamine 2，3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: Association with the induction of allogeneic immune tolerance [J]? Scand J Immunol, 2003, 57(2): 185-191.
|
|
25 Munn DH, Mellor AL. IDO and tolerance to tumors [J]. Trends Mol Med, 2004, 10(1): 15-18.
|
|
26 Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by tryptophan catabolism[J]. Cell Death Differ, 2002, 9(10): 1069-1077.
|
|
27 Lin H, Bolling SF, Linsley PS, et al, Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4-Ig plus donor-specific transfusion[J]. J Exp Med, 1993，178(5): 1801-1806.
|
|
28 Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4-lg [J]. Science, 1992, 257(5071): 789-792.
|
|
29 Grohmann U, Orabona C, Fallarino F, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo [J]. Nat Immunol, 2002, 3(11): 1097-1101.
|
|
30 Orabona C, Puccetti P, Vacca C, et al, Toward the identification of a tolerogenic signature in IDO-competent dendritic cells [J]. Blood, 2006, 107(7): 2846-2854.
|
|
31 Mellor AL, Baban B, Chandler P, et al. Cutting edge: Induced indoleamine 2，3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion [J]. J Immunol, 2003, 171(4): 1652-1655.
|
|
32 Hoffmann P, Boeld TJ, Piseshka B，et al. Immunomodulation after allogeneic bone marrow transplantation by CD4＋CD25＋regulatory T cells [J]. Microbes Infect, 2005, 7(7-8): 1066-1072.
|
|
33 Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype innaive T cells [J]. J Immunol, 2006, 176: 6752-6761.
|
|
34 Curti A, Pandolfi S, Valzasina B, et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25－into CD25＋T regulatory cells[J]. Blood, 2007, 109: 2871-2877.
|
|
35 Fallarino F, Grohmann U, Hwang KW, et al, Modulation of tryptophan catabolism by regulatory T cells [J]. Nat Immunol, 2003, 4(12): 1206-1212.
|